Secondary prevention of ischemic stroke. Guidelines of the American Heart Association and the American Stroke Association 2014
https://doi.org/10.21518/2079-701X-2014-10-17-25
Abstract
Prevention of ischemic stroke (IS) is one of the most pressing healthcare issues, especially in this country, where IS morbidity and mortality are high. The article is a review of literature on secondary prevention of IS in patients after stroke or transient ischemic attack. Recent guidelines for the secondary prevention of IS proposed by the American Heart Association and the American Stroke Association in 2014 are described. Up-to-date methods of secondary prevention of IS will significantly reduce the morbidity and mortality rates in this country.
About the Authors
V. A. Parfyonov
First Moscow State Medical University named after I.M. Sechenov Summary
Russian Federation
Russian Federation
S. V. Verbitskaya
First Moscow State Medical University named after I.M. Sechenov Summary
Russian Federation
Russian Federation
References
1. Дамулин И.В., Парфенов В.А., Скоромец А.А., Яхно Н.Н. Нарушения кровообращения в головном и спинном мозге. Болезни нервной системы. Руководство для врачей. Под ред. Н.Н. Яхно. М.: Медицина, 2005, 1: 232-303.
2. Инсульт: диагностика, лечение и профилактика. Под ред. З.А. Суслиной, М.А. Пирадова М.: МЕДпресс-информ, 2008.
3. Скворцова В.И., Губский Л.В., Стаховская Л.В. и др. Ишемический инсульт. Неврология, национальное руководство. Под ред. Е.И. Гусева, А.И. Коновалова, В.И. Скворцовой. М.: «ГЭОТАР-МЕДИА», 2009: 592-615.
4. Парфенов В.А., Хасанова Д.Р. Ишемический инсульт. М.: МИА, 2012: 288.
5. Sacco RL, Adams R, Albers G et al. Guidelines for Prevention of Stroke in Patients With Ischemic Stroke or Transient Ischemic Attack: A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association Council on Stroke: Co-Sponsored by the Council on Cardiovascular Radiology and Intervention: The American Academy of Neurology affirms the value of this guideline. Stroke. 2006, 37: 577-617.
6. European Stroke Organisation (ESO) Executive Committee; ESO Writing Committee. Guidelines for management of ischaemic stroke and transient ischaemic attack. Cerebrovasc Dis. 2008, 25: 457-507.
7. Furie KL, Kasner SE, Adams RJ et al. Guidelines for the Prevention of Stroke in Patients With Stroke or Transient Ischemic Attack A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association. Stroke. 2011, 42: 227-276.
8. Kernan WN, Ovbiagele B, Black HR et al. Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association. Stroke. published online May 1, 2014 DOI: 10.1161/ STR.0000000000000024.
9. Wannamethee SG, Shaper AG, Whincup PH, Walker M. Smoking cessation and the risk of stroke in middle-aged men.JAMA. 1995, 274: 155-160.
10. Lee CD, Folsom AR, Blair SN. Physical activity and stroke risk: a meta-analysis. Stroke. 2003, 34: 2475-2481.
11. Gillman M, Cupples L, Posner B et al: Protective effects of fruits and vegetables on development of stroke in men. JAMA 1995, 273: 1113-1117.
12. Verdecchia P, Staessen JA, Angeli F et al: Usual versus tight control of systolic blood pressure in non-diabetic patients with hypertension (Cardio-Sis): an open-label randomised trial. Lancet 2009, 374: 525-533.
13. Lawes CMM, Bennett DA, Feigin VL, Rodgers A. Blood pressure and stroke: an overview of published reviews. Stroke. 2004, 35: 776-785.
14. Post-stroke antihypertensive treatment study. A preliminary result. PATS Collaborating Group. Chin Med J. 1995, 108: 710-717.
15. PROGRESS Collaborative Group. Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient schaemic attack. Lancet 2001, 358: 1033-1041.
16. Hart RG, Pearce LA, Aguilar MI. Meta-analysis: Antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation. Ann Intern Med. 2007, 146: 857-867.
17. Connolly S, Ezekowitz MD, Ysuf S et al. Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med. 2009, 361: 1139-1151.
18. Patel М^ Mahaffey KW, Garg J et al. Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation. N Engl J Med 2011, 365: 883-891
19. Granger CB, Alexander JH, McMurray JJV et al. Apixaban versus Warfarin in Patients with Atrial Fibrillation. N Engl J Med 2011, 365: 981-992.
20. Antithrombotic Trialists' Collaboration. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ 2002, 324: 71-86.
21. Haas WK, Easton JD, Adams HP et al. A randomised trial comparing ticlopedine hydrochloride with aspirin for the prevention of stroke in high risk patients. NEngl.JMed. 1989, 329: 501-507.
22. CAPRIE Streering Commitee. A randomised, blinded trial of clopidogrel versus aspirin in patients at risk of ischemic events (CAPRIE). Lancet 1996, 348: 1329-1339.
Review
For citations:
Parfyonov VA, Verbitskaya SV. Secondary prevention of ischemic stroke. Guidelines of the American Heart Association and the American Stroke Association 2014. Meditsinskiy sovet = Medical Council. 2014;(10):17-25. (In Russ.) https://doi.org/10.21518/2079-701X-2014-10-17-25
Views:
555
Email this article 